Multicentric Castleman's disease mimicking adult-onset Still's disease

Joint Bone Spine

Volumn 76, Issue 3, 2009, Pages 304-307

  Bianchi, Maria Marta ^a   Narváez, Javier ^a   Santo, Pilar ^a   Ríos Rodriguez, Valeria ^a   de la Fuente, Diana ^a   Roig Vilaseca, Daniel ^b   Nolla, Joan Miquel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b SAP Baix Llobregat Centre   (Spain)

Author keywords

Adult onset Still's disease; Interleukin 6; Multicentric Castleman's disease

Indexed keywords

ALPHA INTERFERON; ATLIZUMAB; CIDOFOVIR; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOSCARNET; GANCICLOVIR; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ADULT ONSET STILL DISEASE; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTICENTRIC ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; POLYARTHRITIS; SPLENOMEGALY; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 67349109180     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.10.005     Document Type: Article

References (41)

1. Dham A., and Peterson B.A. Castleman's disease. Curr Opin Hematol 14 (2007) 354-359
2. Casper C. The aetiology and management of Castleman's disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129 (2005) 3-17
3. Waterston A., and Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol 43 (2004) 698-704
4. Maslovsky I., Uriev L., and Lugassy G. The heterogeneity of Castleman disease: report of five cases and review of the literature. Am J Med Sci 320 (2000) 292-295
5. Peterson B.A., and Frizzera G. Multicentric Castleman's disease. Semin Oncol 20 (1993) 636-647
6. Sharma R., Seth R., Thavaraj V., et al. Multicentric Castleman's disease in two cases. Indian J Pediatr 74 (2007) 1116-1120
7. Kinney M.C., Hummell D.S., Villiger P.M., et al. Increased interleukin-6 (IL-6) production in a young child with clinical and pathological features of multicentric Castleman's disease. J Clin Immunol 14 (1994) 382-391
8. Kingsmore S.F., Silva O.E., Hall B.D., et al. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash. J Rheumatol 20 (1993) 1588-1591
9. Simile Navarte A., Gómez-Rodriguez N., Novoa Sanjurjo F.J., et al. Asymmetric oligoarthritis in Castleman's disease. An Med Interna 15 (1988) 259-261
10. Weisenburger D.D., Nathwani B.N., Winberg C.D., et al. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 16 (1985) 162-172
11. Frizzera G., Peterson B.A., Bayrd E.D., et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3 (1985) 1202-1216
12. Hosaka S., and Kondo H. Three cases of Castleman's disease mimicking the features of collagen disease. Ryumachi 34 (1994) 42-47
13. Efthimiou P., Paik P.K., and Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65 (2006) 564-572
14. Yamaguchi M., Ohta A., Tsunematsu T., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 19 (1992) 424-430
15. Osone S., Morimoto A., Tsutsui J., et al. Systemic juvenile idiopathic arthritis mimics multicentric Castleman's disease. Clin Rheumatol 22 (2003) 484-486
16. Morita-Hoshi Y., Tohda S., Miura O., et al. An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis. Int J Hematol 87 (2008) 69-74
17. Leung K.T., Wong K.M., Choi K.S., et al. Multicentric Castleman's disease complicated by secondary renal amyloidosis. Nephrology (Carlton) 9 (2004) 392-393
18. Fugigaki Y., and Hishida A. Does IL-6 mediate renal manifestations of Castleman's disease. Intern Med 41 (2002) 1086-1087
19. Stansby G., Hilson A., and Hamilton G. Gallium scintigraphy in the diagnosis and management of multifocal Castleman's disease. Br J Radiol 64 (1991) 165-167
20. Okamoto I., Iyonaga K., Fujii K., et al. Absence of gallium uptake in unicentric and multicentric Castleman's disease. Intern Med 42 (2003) 735-739
21. Chim C.S., Choi F.P., Ooi G.C., et al. Absence of gallium uptake in multicentric Castleman's disease of plasma cell type. Haematologica 86 (2001) 442-443
22. Jacobs S.A., Vidnovic N., Patel H., et al. Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman's disease in patient with rheumatoid arthritis treated with methotrexate. Clin Rheumatol 26 (2007) 1148-1150
23. Okaniwa G., and Imai T. Castleman's disease associated rheumatoid arthritis recurring 20 years after removal. Nippon Kyobu Geka Gakkai Zasshi 39 (1991) 452-457
24. Ben-Chetrit E., Flusser D., Okon E., et al. Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis 48 (1989) 326-330
25. Higashi K., Matsuki Y., Hidaka T., et al. Primary Sjögren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia. Scand J Rheumatol 26 (1997) 482-484
26. Tavoni A., Vitali C., Baglioni P., et al. Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. Rheumatol Int 12 (1993) 251-253
27. Kojima M., Motoori T., Asano S., et al. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract 203 (2007) 423-431
28. Suwannaroj S., Elkins S.L., and McMurray R.W. Systemic lupus erythematosus and Castleman's disease. J Rheumatol 26 (1999) 1400-1403
29. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1 (2006) 273-296
30. Carbone A., and Gloghini A. HHV-8-associated lymphoma: state-of-the-art review. Acta Haematol 117 (2007) 129-131
31. Gessain A., Sudaka A., Briere J., et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients?. Blood 87 (1996) 414-416
32. Soulier J., Grollet L., Oksenhendler F., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 (1995) 1276-1280
33. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8 Suppl. 2 (2006) S2
34. Efthimiou P., and Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 36 (2006) 144-152
35. Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 56 (1985) 2446-2451
36. Herrada J., Cabanillas F., Rice L., et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128 (1998) 657-662
37. Chronowski G.M., Ha C.S., Wilder R.B., et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92 (2001) 670-676
38. Corbellino M., Bestetti G., Scalamogna C., et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98 (2001) 3473-3475
39. Ide M., Kawachi Y., Izumi Y., et al. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab. Eur J Haematol 76 (2006) 119-123
40. Matsuyama M., Suzuki T., Tsuboi H., et al. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Intern Med 46 (2007) 771-774
41. Nishimoto N., Kanakura Y., Aozasa K., et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106 (2005) 2627-2632